冠昊生物 (300238.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(冠昊生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 88,437,338.7998,256,929.2591,441,252.3695,229,683.7898,134,142.3898,129,960.30112,684,910.79
 营业收入(元) 88,437,338.7998,256,929.2591,441,252.3695,229,683.7898,134,142.3898,129,960.30112,684,910.79
二、营业总成本(元) 88,955,084.2589,215,693.2871,751,172.33102,477,803.6479,780,643.6091,195,849.1987,034,936.18
 营业成本(元) 17,338,524.3722,008,950.8820,070,872.0923,873,746.6813,261,246.3021,626,283.8025,605,230.31
 研发费用(元) 12,064,919.288,544,373.327,484,200.5313,958,421.0610,336,634.4010,641,075.679,567,734.69
 营业税金及附加(元) 907,846.161,094,807.41853,805.681,240,963.04976,395.001,148,964.321,000,958.77
 销售费用(元) 44,520,622.3743,000,369.4830,734,582.3842,272,552.2641,443,953.6346,041,947.5336,778,009.09
 管理费用(元) 13,884,595.1414,292,285.5612,473,774.8618,161,634.9113,492,597.4110,116,718.0413,595,191.91
 财务费用(元) 238,576.93274,906.63133,936.792,970,485.69269,816.861,620,859.83487,811.41
  其中:利息费用(元) 146,850.00153,291.68159,791.67391,280.27371,976.17492,442.85526,665.06
  其中:利息收入(元) 194,519.56144,502.61130,992.97354,323.65386,622.57393,238.20368,610.32
 资产减值损失(元) -78,147.20-150,825.78264,385.52-617,036.19-5,633,524.272,467,660.24-107,792.58
 信用减值损失(元) -2,022,727.43-3,913,202.08-524,388.33-4,602,877.91-1,702,769.57-2,301,950.19-670,636.77
三、其他经营收益
 加:投资收益(元) 1,209,736.47-274,995.16-129,015.63-95,069.17-1,439,055.72-2,012,948.30-93,124.14
  其中:对联营企业和合营企业的投资收益(元) -127,638.90-248,154.05-129,015.63-95,068.27-128,413.23-163,928.30-93,124.14
 资产处置收益(元) 585.00-205.001,090.00929,125.14---5,019.56
 其他收益(元) 6,849,218.54833,836.451,218,321.801,268,147.41926,206.731,008,221.182,981,540.83
四、营业利润(元) 5,440,919.925,535,844.4020,520,473.39-10,365,830.5810,504,355.956,095,094.0427,754,942.39
 加:营业外收入(元) 9,307.932,014.88270.15-89,790.994,445.24-12,830.66109,347.65
 减:营业外支出(元) -5,358.14139,865.2040,325.661,438,200.46419,399.9313,250.1339,688.06
五、利润总额(元) 5,455,585.995,397,994.0820,480,417.88-11,893,822.0310,089,401.266,069,013.2527,824,601.98
 减:所得税费用(元) 1,555,998.924,113,437.695,005,638.045,166,625.002,162,290.47-63,071.343,750,812.81
六、净利润(元) 3,899,587.071,284,556.3915,474,779.84-17,060,447.037,927,110.796,132,084.5924,073,789.17
(一)按经营持续性分类
  持续经营净利润(元) 3,899,587.071,284,556.3915,474,779.84-17,060,447.037,927,110.796,132,084.5924,073,789.17
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 7,687,894.205,756,929.5814,391,514.75-10,265,528.6910,527,950.108,628,111.4722,115,265.70
  少数股东损益(元) -3,788,307.13-4,472,373.191,083,265.09-6,794,918.34-2,600,839.31-2,496,026.881,958,523.47
 扣除非经常性损益后的净利润(元) 1,311,942.874,955,972.4713,967,060.93-7,540,026.5510,539,191.367,834,449.1119,721,782.62
七、每股收益
 一、基本每股收益(元) 0.020.030.05-0.040.040.040.08
 二、稀释每股收益(元) 0.020.030.05-0.040.040.040.08
八、其他综合收益(元) -70,746.2339,577.12-80,925.931,573,686.411,454,624.42-515,056.301,730,956.42
 归属于母公司股东的其他综合收益(元) -70,746.2339,577.12-80,925.931,573,686.411,454,624.42-515,056.301,730,956.42
九、综合收益总额(元) 3,828,840.841,324,133.5115,393,853.91-15,486,760.629,381,735.215,617,028.2925,804,745.59
 归属于母公司所有者的综合收益总额(元) 7,617,147.975,796,506.7014,310,588.82-8,691,842.2811,982,574.528,113,055.1723,846,222.12
 归属于少数股东的综合收益总额(元) -3,788,307.13-4,472,373.191,083,265.09-6,794,918.34-2,600,839.31-2,496,026.881,958,523.47
公告日期 2024-10-292024-08-282024-04-262024-03-062023-10-252023-08-232023-04-20
审计意见(境内) 标准无保留意见

前瞻产业研究院